Literature DB >> 8640225

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

D W Johnson1, J N Berg, M A Baldwin, C J Gallione, I Marondel, S J Yoon, T T Stenzel, M Speer, M A Pericak-Vance, A Diamond, A E Guttmacher, C E Jackson, L Attisano, R Kucherlapati, M E Porteous, D A Marchuk.   

Abstract

Hereditary haemorrhagic telangiectasia, or Osler-Rendu-Weber (ORW) syndrome, is an autosomal dominant vascular dysplasia. So far, two loci have been demonstrated for ORW. Linkage studies established an ORW locus at chromosome 9q3; endoglin was subsequently identified as the ORW1 gene. A second locus, designated ORW2, was mapped to chromosome 12. Here we report a new 4 cM interval for ORW2 that does not overlap with any previously defined. A 1.38-Mb YAC contig spans the entire interval. It includes the activin receptor like kinase 1 gene (ACVRLK1 or ALK1), a member of the serine-threonine kinase receptor family expressed in endothelium. We report three mutations in the coding sequence of the ALK1 gene in those families which show linkage of the ORW phenotype to chromosome 12. Our data suggest a critical role for ALK1 in the control of blood vessel development or repair.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640225     DOI: 10.1038/ng0696-189

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  307 in total

Review 1.  Supermodels and disease: insights from the HHT mice.

Authors:  C L Shovlin
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  Pathogenesis of hemangioma.

Authors:  D A Marchuk
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 3.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

4.  High-resolution transcript map of the region spanning D12S1629 and D12S312 at chromosome 12q13: triple A syndrome-linked region.

Authors:  H Lee; E Choi; Y Seomun; K Montgomery; A Huebner; E Lee; S Lau; C K Joo; R Kucherlapati; S J Yoon
Journal:  Genome Res       Date:  2000-10       Impact factor: 9.043

Review 5.  Pulmonary arteriovenous malformations: a clinical review.

Authors:  M Iqbal; L J Rossoff; H N Steinberg; K A Marzouk; D N Siegel
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

Review 6.  Pulmonary hypertension in the young.

Authors:  Sheila G Haworth
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

7.  Decreased levels of miR-28-5p and miR-361-3p and increased levels of insulin-like growth factor 1 mRNA in mononuclear cells from patients with hereditary hemorrhagic telangiectasia 1.

Authors:  Anthony Cannavicci; Qiuwang Zhang; Si-Cheng Dai; Marie E Faughnan; Michael J B Kutryk
Journal:  Can J Physiol Pharmacol       Date:  2018-12-04       Impact factor: 2.273

Review 8.  Fishing for novel angiogenic therapies.

Authors:  Kameha R Kidd; Brant M Weinstein
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

9.  The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study.

Authors:  Benedikt J Folz; Ana Cerra Wollstein; Heiko Alfke; Anja A Dünne; Burkard M Lippert; Konrad Görg; Hans-Joachim Wagner; Siegfried Bien; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

10.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.

Authors:  R E Harrison; J A Flanagan; M Sankelo; S A Abdalla; J Rowell; R D Machado; C G Elliott; I M Robbins; H Olschewski; V McLaughlin; E Gruenig; F Kermeen; M Halme; A Räisänen-Sokolowski; T Laitinen; N W Morrell; R C Trembath
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.